Yamamoto Y - Search Results

1

STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart.

Oshima Y, Fujio Y, Nakanishi T, Itoh N, Yamamoto Y, Negoro S, Tanaka K, Kishimoto T, Kawase I, Azuma J. Oshima Y, et al. Among authors: yamamoto y. Cardiovasc Res. 2005 Feb 1;65(2):428-35. doi: 10.1016/j.cardiores.2004.10.021. Cardiovasc Res. 2005. PMID: 15639482

2

Identification of cardiac myocytes as the target of interleukin 11, a cardioprotective cytokine.

Kimura R, Maeda M, Arita A, Oshima Y, Obana M, Ito T, Yamamoto Y, Mohri T, Kishimoto T, Kawase I, Fujio Y, Azuma J. Kimura R, et al. Among authors: yamamoto y. Cytokine. 2007 May;38(2):107-15. doi: 10.1016/j.cyto.2007.05.011. Epub 2007 Jul 16. Cytokine. 2007. PMID: 17629706

3

Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.

Yamamoto Y, Hoshino Y, Ito T, Nariai T, Mohri T, Obana M, Hayata N, Uozumi Y, Maeda M, Fujio Y, Azuma J. Yamamoto Y, et al. Cardiovasc Res. 2008 Jul 1;79(1):89-96. doi: 10.1093/cvr/cvn076. Epub 2008 Mar 17. Cardiovasc Res. 2008. PMID: 18346979

4

Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome.

Takatani T, Takahashi K, Uozumi Y, Shikata E, Yamamoto Y, Ito T, Matsuda T, Schaffer SW, Fujio Y, Azuma J. Takatani T, et al. Among authors: yamamoto y. Am J Physiol Cell Physiol. 2004 Oct;287(4):C949-53. doi: 10.1152/ajpcell.00042.2004. Epub 2004 Jul 14. Am J Physiol Cell Physiol. 2004. PMID: 15253891 Free article.

5

Connective tissue growth factor induces cardiac hypertrophy through Akt signaling.

Hayata N, Fujio Y, Yamamoto Y, Iwakura T, Obana M, Takai M, Mohri T, Nonen S, Maeda M, Azuma J. Hayata N, et al. Among authors: yamamoto y. Biochem Biophys Res Commun. 2008 May 30;370(2):274-8. doi: 10.1016/j.bbrc.2008.03.100. Epub 2008 Mar 28. Biochem Biophys Res Commun. 2008. PMID: 18375200

6

Cellular characterization of taurine transporter in cultured cardiac myocytes and nonmyocytes.

Takatani T, Takahashi K, Itoh T, Takahashi K, Hirata M, Yamamoto Y, Ohmoto M, Schaffer SW, Azuma J. Takatani T, et al. Among authors: yamamoto y. Adv Exp Med Biol. 2003;526:25-31. doi: 10.1007/978-1-4615-0077-3_4. Adv Exp Med Biol. 2003. PMID: 12908580 No abstract available.

7

Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress.

Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S. Fukuda K, et al. Among authors: yamamoto y. Biochem Biophys Res Commun. 2007 Sep 28;361(3):670-4. doi: 10.1016/j.bbrc.2007.07.088. Epub 2007 Jul 25. Biochem Biophys Res Commun. 2007. PMID: 17673169

8

Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus.

Yoneda T, Takeda Y, Usukura M, Oda N, Takata H, Yamamoto Y, Karashima S, Yamagishi M. Yoneda T, et al. Among authors: yamamoto y. Am J Hypertens. 2007 Dec;20(12):1329-33. doi: 10.1016/j.amjhyper.2007.09.001. Am J Hypertens. 2007. PMID: 18047925 Clinical Trial.

9

Medical treatment of benign insulinoma using octreotide LAR: a case report.

Usukura M, Yoneda T, Oda N, Yamamoto Y, Takata H, Hasatani K, Takeda Y. Usukura M, et al. Among authors: yamamoto y. Endocr J. 2007 Feb;54(1):95-101. doi: 10.1507/endocrj.k05-157. Epub 2006 Nov 24. Endocr J. 2007. PMID: 17124362 Free article.

10

NEK9 regulates primary cilia formation by acting as a selective autophagy adaptor for MYH9/myosin IIA.

Yamamoto Y, Chino H, Tsukamoto S, Ode KL, Ueda HR, Mizushima N. Yamamoto Y, et al. Nat Commun. 2021 Jun 2;12(1):3292. doi: 10.1038/s41467-021-23599-7. Nat Commun. 2021. PMID: 34078910 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,335 results

Search Page

Filters